Xconomy |
Cambridge startup Synlogic to go public through reverse merger
The Boston Globe Two-year-old Cambridge startup Synlogic Inc., which is synthetically engineering microbes into disease-fighting drugs, said Tuesday that it has struck an unusual deal to allow it to go public this summer through a reverse merger with a Texas shell company. Synlogic and Mirna Therapeutics Agree to MergerBusiness Wire (press release) |
May 16, 2017 at 03:45PM
from
No comments:
Post a Comment